x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:22:27

Perspectives From Latin America on Advances in HIV PrEP

Decera Clinical Education Infectious Disease Podcast ·

2023/02/17

In this episode, 2 HIV experts from Latin America share their thoughts on the current status of HIV prevention strategies in the region, including recent successes and ongoing challenges. Specifically, the faculty discuss:Barriers that limit PrEP availability in many regions of Latin America despite the high need among vulnerable and at-risk groupsSuccessful expansion of PrEP access in BrazilKey findings from the prospective ImPrEP study evaluating implementation of same-day oral PrEP among men who

en

00:22:04

Australian Perspectives on Advances in HIV

Decera Clinical Education Infectious Disease Podcast ·

2023/02/17

In this episode, 2 Australian HIV experts share their thoughts on some of the most important HIV insights gained during the past year in the context of HIV care in Australia.Specifically, the faculty discuss the continued dominance of second-generation INSTI-based regimens as mainstay HIV therapy in Australia, including in both 2-drug and 3-drug oral regimens; the emergence of 2-drug long-acting injectable therapy as a switch strategy; key aspects of successfully expanded oral PrEP programs in the

en

00:22:00

European Perspectives on Advances in HIV Treatment

Decera Clinical Education Infectious Disease Podcast ·

2023/02/17

In this episode, 2 European HIV experts share their thoughts on some of the most important new antiretroviral therapy insights from HIV research over the past year.Specifically, the faculty discuss findings from real-world and long-term studies of 2-drug oral regimens, the latest on 2-drug long-acting injectable therapy, how 2-drug options fit into rapid start strategies, and other new and emerging innovations in HIV treatment, including the availability of lenacapavir for multidrug-resistant HIV

en

00:44:10

Diagnosis and Management of Patients With Long COVID

Decera Clinical Education Infectious Disease Podcast ·

2023/01/31

In this episode, Alba Azola, MD, and Monica Verduzco-Gutierrez, MD, discuss diagnosis and management of long COVID, including: Definitions of post COVID conditionsDiagnosis, including symptoms and clinical presentationEpidemiologyRisk factorsPossible treatment optionsClinical guidance statementsPresenters:Alba Azola, MDAssistant ProfessorDepartment of Physical Medicine and RehabilitationJohns HopkinsCo-DirectorJohns Hopkins Post Acute COVID Team ClinicBaltimore, MarylandMonica Verduzco-Gutierrez,

en

00:05:46

The Role of College Campuses in HIV PrEP Uptake

Decera Clinical Education Infectious Disease Podcast ·

2023/01/31

In this episode, Kenric Ware, PharmD, AAHIVP, discusses the role of college campuses in HIV pre-exposure prophylaxis (PrEP) uptake for adolescents, including the following.PrEP awareness and educationVenues for ongoing PrEP conversations, including in-person dormitory discussions, virtual webinars, and social media conversationsCampus health clinics that are safe and trusting and minimize stigmaIndividualized approaches, including:Engaging local students in discussions of regional barriers and

en

00:05:07

How Clinic Facilities Can Prepare for Long-Acting...

Decera Clinical Education Infectious Disease Podcast ·

2023/01/18

In this episode, Eric Florence, MD, PhD, discusses how clinics can prepare for the implementation of long-acting injectable antiretroviral therapy, including:Clinical infrastructureEnsuring adequate space and injection equipmentMaintaining drug supply and temperature requirementsStaffingEnsuring there are staff able to focus on the implementation of LA ART, including well-trained nurses to administer the injectionsImplementing a system for scheduling follow-up injections and providing patient

en

00:23:00

Questions Answered on ART Safety and Tolerability in...

Decera Clinical Education Infectious Disease Podcast ·

2023/01/17

In this episode, Marta Boffito, MD, PhD, FRCP, and Jens D. Lundgren, MD, DMSc, address key considerations when evaluating antiretroviral therapy safety and tolerability in aging patients and those with possible cardiometabolic toxicities, including:Monitoring for cardiometabolic syndromes (eg, lipid panels, coronary artery calcification scores)Approaching antiretroviral-related weight gain in clinical practiceInterpreting results from RESPOND on cardiovascular risk with integrase strand transfer

en

00:40:04

Emerging Insights on Outpatient Management of Acute...

Decera Clinical Education Infectious Disease Podcast ·

2023/01/13

In this episode, Jens D. Lundgren, MD, DMSc, and Barbara Rath, MD, PhD, HDR, discuss emerging insights on outpatient management of acute COVID-19 and long COVID in Europe, including:Current COVID-19 variant and subvariant landscapeCOVID-19 treatments, including antivirals and monoclonal antibodiesESCMID COVID-19 treatment guidelinesLong COVID causes and pathophysiologyPrevention and management of long COVIDPresenters:Jens D. Lundgren, MD, DMScProfessorRigshospital, University of

en

00:08:48

Administration of LA ART by Community Nurses in France

Decera Clinical Education Infectious Disease Podcast ·

2023/01/05

In this episode, Laurence Slama, MD, PhD, describes some of the ways that her clinic is attempting to make IM injections of long-acting antiretroviral therapy more sustainable long term. She explains the logistics of how she has allowed for patients to receive their long-acting cabotegravir and rilpivirine doses through community nurses after receiving the first 3 doses in a clinical setting. She also discusses some of the benefits and challenges of this kind of flexible system for patients and

en

00:19:06

Optimizing PrEP Selection and Persistence for MSM

Decera Clinical Education Infectious Disease Podcast ·

2023/01/05

In this episode, Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, discusses optimizing HIV pre-exposure prophylaxis (PrEP) selection and persistence for men who have sex with men (MSM), including:Disparities in PrEP uptake for MSMWhat healthcare professionals can do to address disparities in PrEP uptakeProviding PrEP within a program that includes sexual health and primary care services, in addition to prescribing PrEPPrEP medication options for MSMHelping patients access PrEP

en

00:17:59

PrEP Considerations for Transgender and Nonbinary...

Decera Clinical Education Infectious Disease Podcast ·

2023/01/05

In this episode, Jill Blumenthal, MD, MAS, discusses HIV pre-exposure prophylaxis (PrEP) considerations for transgender and nonbinary individuals, including:Providing gender-affirming careIntegrating PrEP and gender careTaking a sexual history and addressing sexual healthPrEP efficacy and options for transgender individuals, including FTC/TDF, FTC/TAF, and long-acting CABThe importance of reassuring transgender individuals that data suggest there are no drug–drug interactions between

en

00:07:27

Should We Be Concerned About Resistance and...

Decera Clinical Education Infectious Disease Podcast ·

2023/01/04

Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 treatments and the possibility for antiviral resistance, including:Treatment resistance mechanismsCOVID-19 testingCOVID-19 treatments, including antivirals and monoclonal antibodiesPresenters:Fernando Carnavali, MDAssociate Professor of MedicineDivision ChiefGeneral Internal MedicineDepartment of MedicineSite DirectorCOVID Center of Excellence Satellite-Ansonia Mount Sinai

en

00:05:28

What Strategies Are Most Promising for Prevention and...

Decera Clinical Education Infectious Disease Podcast ·

2023/01/04

Fernando Carnavali, MD; Rasika Karnik, MS, MD; and Renslow Sherer, MD, discuss long COVID, including:Long COVID prevention strategies, including COVID-19 vaccinationLong COVID treatment approachesStrategies for management of patients with long COVIDPresenters:Fernando Carnavali, MDAssociate Professor of MedicineDivision ChiefGeneral Internal MedicineDepartment of MedicineSite DirectorCOVID Center of Excellence Satellite-Ansonia Mount Sinai Health New York, New YorkRasika Karnik, MS, MDAssistant

en

00:10:03

ART Selection in Treatment-Naive PWH: Weight Gain...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/30

In this episode, Princy N. Kumar, MD, FIDSA, MACP, discusses key considerations for selecting ART in treatment-naive persons with HIV. Her discussion includes a review of the following studies on ART and weight gain:ADVANCE: men vs women receiving DTG + FTC/TAF, DTG + FTC/TDF, and EFV + FTC/TDFComparison of ART regimens (eg, INSTI-, NNRTI- and PI-based regimens) in a pooled analysis of 8 phase III randomized controlled trialsGEMINI-1 and GEMINI-2: DTG + 3TC vs DTG + FTC/TDFPresenter:Princy N. Kumar,

en

00:04:48

Should We Be Concerned About Viral Rebound With...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/30

Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss COVID-19 rebound, including:Prevalence of COVID-19 reboundCOVID-19 rebound and antiviral useManagement of COVID-19 rebound Presenters:Fernando Carnavali, MDAssociate Professor of MedicineDivision ChiefGeneral Internal MedicineDepartment of MedicineSite Director COVID Center of Excellence Satellite-Ansonia Mount Sinai Health New York, New YorkRasika Karnik, MS, MDAssistant ProfessorDivision

en

00:23:23

Selecting First-line ART in Treatment-Naive Persons...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/29

In this episode, Princy N. Kumar, MD, FIDSA, MACP, discusses key considerations for selecting ART in treatment-naive persons with HIV. Her discussion includes:DHHS Treatment Guideline recommendationsChoosing among first-line recommended integrase inhibitorsRecommended regimens for rapid ART startSelect key studies in treatment-naïve adults:AMBER study of virologic response with DRV/COBI/FTC/TAF vs DRV/COBI + TFC/TDFDRIVE-AHEAD and DRIVE-FORWARD efficacy study results, including resistance analyses

en

00:07:42

If Treatment Supply Is Limited in Future COVID-19...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/29

Fernando Carnavali, MD; Rasika Karnik, MS, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss how to ethically prioritize patients for COVID-19 treatment when treatment supplies may be limited, including insights on:Risk stratificationMedication acquisitionDrug interactionsPresenters:Fernando Carnavali, MDAssociate Professor of MedicineDivision ChiefGeneral Internal MedicineDepartment of MedicineSite Director COVID Center of Excellence Satellite-Ansonia Mount Sinai Health New York,

en

00:11:09

Promoting Meningococcal Vaccine Equity in Adolescent...

Decera Clinical Education Infectious Disease Podcast ·

2022/12/29

In this episode, Tamera Coyne-Beasley, MD, MPH, discusses strategies to address barriers to improve meningococcal vaccination rates by addressing social determinants of health and minimizing vaccine inequities, such as:Working closely with members of the community, including community-based organizations and adolescent and young adult influencersInvolving all youth when designing vaccination outreach and messaging programsCreating and evaluating the use of technologyUsing graphics, voices, and

en

00:04:51

Will New COVID-19 Vaccines Affect Risk Stratification?

Decera Clinical Education Infectious Disease Podcast ·

2022/12/27

Fernando Carnavali, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss how new COVID-19 vaccines may affect risk stratification, including:Omicron-specific vaccineRole of vaccination in risk stratificationPresenters:Fernando Carnavali, MDAssociate Professor of MedicineDivision ChiefGeneral Internal MedicineDepartment of MedicineSite Director COVID Center of Excellence Satellite-AnsoniaMount Sinai Health SystemNew York, New YorkRenslow Sherer, MDDirectorInternational HIV Training

en

00:18:21

The Future of Long-Acting HIV Care: What’s Still Needed

Decera Clinical Education Infectious Disease Podcast ·

2022/12/22

In this episode, an international expert panel shares their thoughts on what will be needed from future long-acting HIV treatment and prevention strategies to address populations who are not eligible for currently available long-acting options. The faculty members also discuss important considerations for leveraging long-acting HIV approaches to address care inequities across different populations.Other episodes in this 4-part series cover additional aspects of long-acting antiretrovirals for HIV

en

497 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College